WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
CN Stock MarketDetailed Quotes
600519 Kweichow Moutai
- 1568.88
- +19.86+1.28%
Market Closed Apr 3 15:00 CST
1.97TMarket Cap22.86P/E (TTM)
1586.00High1529.01Low35.48KlotVolume1530.00Open1549.02Pre Close5.56BTurnover0.28%Turnover Ratio22.86P/E (Static)1.26BShares1886.1252wk High8.45P/B1.97TFloat Cap1221.9552wk Low1703.92Limit Up1.26BShs Float2465.23Historical High1394.12Limit Down3.68%Amplitude-234.81Historical Low54.76Dividend TTM1566.34Avg Price12.62KlotAsk3.49%Div YieldTTM100Lot Size17.59KlotBid
Kweichow Moutai Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -14.15%59.3B | -14.94%60.08B | -19.40%56.84B | 2.41%74.2B | 18.53%69.07B | 21.49%70.64B | 21.49%70.52B | 28.51%72.45B | 12.48%58.27B | 14.68%58.15B |
| Transactional financial assets | -37.98%248.51M | -94.28%200.79M | 1,815.05%3.83B | --3.81B | --400.71M | --3.51B | --199.92M | ---- | ---- | ---- |
| Notes receivable and accounts receivable | 2,596.09%2B | 783.42%1.16B | 922.68%333.1M | 266.04%213.8M | -41.21%74.31M | -10.16%131.21M | -77.41%32.57M | --58.41M | --126.39M | -72.96%146.06M |
| -Notes receivable | 14,142.05%1.98B | --1.15B | --331.74M | --140.68M | -86.79%13.93M | ---- | ---- | ---- | --105.45M | -72.96%146.06M |
| -Accounts receivable | -68.57%18.97M | -92.28%10.13M | -95.83%1.36M | 25.19%73.12M | 188.36%60.37M | --131.21M | --32.57M | --58.41M | --20.94M | ---- |
| Other receivables (including interest and dividends) | 8.92%29.96M | -1.55%63.22M | -11.22%53.6M | -20.59%26.3M | -13.57%27.5M | 21.84%64.21M | 23.16%60.37M | -27.53%33.12M | -4.04%31.82M | 2.10%52.7M |
| -Other receivable | 8.92%29.96M | ---- | -11.22%53.6M | ---- | -13.57%27.5M | ---- | 23.16%60.37M | ---- | -4.04%31.82M | ---- |
| Advance payment | -22.00%26.98M | -62.25%41.75M | -76.26%24.31M | -56.40%41.2M | -96.15%34.59M | -79.75%110.59M | -61.80%102.38M | -64.05%94.51M | 130.62%897.38M | -46.16%546.16M |
| Inventories | 17.03%54.34B | 17.65%48.22B | 16.88%47.77B | 16.98%46.85B | 19.60%46.44B | 16.51%40.99B | 17.08%40.87B | 18.57%40.05B | 16.26%38.82B | 15.76%35.18B |
| Non-current assets due within one year | --1.21B | --154.14M | --152.87M | ---- | ---- | ---- | ---- | ---- | --2.12B | ---- |
| Other current assets | 124.32%160.18M | -54.29%19.75M | 14.38%55.89M | -23.57%61.06M | -55.61%71.4M | 28.75%43.21M | 27.19%48.86M | -24.19%79.89M | 124.87%160.84M | 15.41%33.56M |
| Total current assets | 11.79%251.73B | 9.13%238.42B | 14.39%232.26B | 8.79%237.38B | 3.95%225.17B | 3.73%218.47B | -0.24%203.03B | 1.11%218.2B | -1.88%216.61B | 9.36%210.61B |
| Non Current assets | ||||||||||
| Debt investment | -71.54%1.52B | 129.59%3.23B | 129.72%3.21B | 285.33%5.34B | 1,298.27%5.32B | 660.21%1.41B | 704.66%1.4B | 705.41%1.38B | 123.32%380.69M | 789.07%184.89M |
| Other non-current financial assets | 0.66%4.03B | 0.28%4.01B | --4.01B | --4B | --4B | --4B | ---- | ---- | ---- | ---- |
| Investment real estate | 84.25%7.63M | -1.22%4.38M | 1.04%4.55M | -13.43%3.96M | -22.43%4.14M | -17.98%4.44M | -17.91%4.51M | -17.84%4.57M | 1.77%5.34M | 1.85%5.41M |
| Fixed assets | 9.86%21.87B | ---- | 3.06%19.83B | ---- | 0.84%19.91B | ---- | 10.00%19.24B | ---- | 12.99%19.74B | ---- |
| Constru in process | 0.57%2.15B | ---- | -4.41%2.56B | ---- | -3.21%2.14B | ---- | 0.40%2.68B | ---- | -4.89%2.21B | ---- |
| Intangible assets | 3.24%8.85B | 2.75%8.67B | 4.03%8.72B | 1.05%8.52B | 21.02%8.57B | 25.16%8.44B | 23.87%8.38B | 24.49%8.43B | 14.09%7.08B | 28.66%6.74B |
| Development expenditure | -54.81%98.52M | -38.60%160.77M | -40.18%162.99M | 2.58%222.43M | 14.42%218.02M | 217.64%261.83M | 287.04%272.47M | 229.66%216.82M | --190.54M | --82.43M |
| Long deferred expense | -4.97%152.11M | 9.16%154.46M | 9.91%157.96M | 8.01%157.77M | 9.29%160.06M | 4.83%141.51M | 4.72%143.71M | 6.84%146.07M | 5.10%146.46M | -4.21%134.99M |
| Deferred tax assets | 18.81%5.52B | 21.65%5.91B | 21.46%4.97B | 28.90%4.48B | 29.23%4.65B | 31.16%4.86B | 30.65%4.1B | 49.21%3.47B | 60.69%3.59B | 168.72%3.7B |
| Usufruct assets | 30.68%410.59M | -3.63%306.14M | -7.36%310.92M | -18.23%315.72M | -21.95%314.21M | -15.14%317.67M | 9.97%335.6M | 10.76%386.14M | 10.96%402.55M | -20.60%374.36M |
| Other non current assets | 112.11%232.4M | --213.89M | --200.75M | --154.01M | --109.56M | ---- | ---- | ---- | ---- | 3.12%2.11B |
| Total non current assets | -0.65%47.22B | 10.89%48.35B | 21.72%46.95B | 19.80%48.15B | 25.44%47.53B | 17.37%43.6B | 6.17%38.57B | 13.20%40.19B | 10.14%37.89B | 15.64%37.15B |
| Total assets | 9.62%298.94B | 9.42%286.77B | 15.56%279.21B | 10.50%285.52B | 7.15%272.7B | 5.78%262.08B | 0.73%241.6B | 2.82%258.39B | -0.26%254.5B | 10.26%247.76B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | 13.64%3.51B | 23.21%2.65B | 66.03%3.29B | 52.37%4.02B | 28.43%3.09B | 43.45%2.15B | 27.42%1.98B | 65.80%2.64B | 19.83%2.41B | 37.77%1.5B |
| -Accounts payable | 13.64%3.51B | 23.21%2.65B | 66.03%3.29B | 52.37%4.02B | 28.43%3.09B | 43.45%2.15B | 27.42%1.98B | 65.80%2.64B | 19.83%2.41B | 37.77%1.5B |
| Contract liabilities | -32.09%9.59B | -12.85%9.93B | 36.25%9.99B | 14.33%9.52B | -8.70%14.13B | -3.73%11.39B | -24.14%7.33B | 0.10%8.33B | 21.65%15.47B | 29.55%11.84B |
| Salaries payable | 7.82%5.82B | 4.47%446.95M | 16.41%432.2M | 71.78%764.26M | 12.96%5.4B | 12.61%427.84M | 6.29%371.27M | 39.50%444.91M | 30.03%4.78B | 53.34%379.91M |
| Taxs payable | 11.05%7.72B | 7.30%6.34B | -6.12%5.81B | 2.23%7.02B | 0.77%6.95B | 21.90%5.91B | 27.16%6.19B | -11.88%6.86B | -42.43%6.9B | -7.02%4.85B |
| Other payable (including interest and dividends) | 4.14%5.43B | -2.27%5.63B | 10.91%6.44B | 35.57%5.72B | 14.73%5.21B | 5.07%5.76B | -13.24%5.81B | -17.63%4.22B | 10.17%4.54B | 16.09%5.49B |
| -Dividend payable | ---- | -34.28%57M | ---- | ---- | ---- | --86.73M | -63.52%478.23M | ---- | ---- | ---- |
| -Other payable | 4.14%5.43B | ---- | 20.86%6.44B | ---- | 14.73%5.21B | ---- | -0.99%5.33B | ---- | 10.17%4.54B | ---- |
| Non current liabilities due within one year | 96.22%111.95M | -23.15%47.93M | -13.00%60.41M | -37.78%56.13M | -47.82%57.05M | -45.15%62.37M | -14.49%69.44M | -18.58%90.21M | 4.82%109.35M | 25.08%113.7M |
| Other current liabilities | -32.91%1.22B | -13.38%1.24B | 36.67%1.24B | 16.84%1.15B | -7.92%1.82B | -0.19%1.43B | -22.20%907.08M | 4.45%980.47M | 28.86%1.98B | 26.89%1.43B |
| Total current liabilities | 16.05%56.52B | 5.62%38.72B | 58.99%50.81B | 16.54%36.63B | -0.75%48.7B | 7.83%36.66B | -22.31%31.96B | -12.96%31.43B | -15.28%49.07B | -21.74%34B |
| Current liabilities | ||||||||||
| Deferred tax liabilities | 30.94%103.37M | -6.99%74.82M | -6.85%78.16M | -50.29%80.84M | -51.46%78.94M | --80.44M | --83.9M | --162.63M | --162.63M | ---- |
| Lease liabilities | 17.73%313.91M | -9.39%283.85M | -12.64%277.41M | -16.58%280.27M | -20.28%266.64M | 1.21%313.27M | 21.70%317.56M | 17.03%335.97M | 12.81%334.45M | -29.51%309.52M |
| Total non current liabilities | 20.75%417.27M | -8.90%358.67M | -11.43%355.57M | -27.58%361.1M | -30.48%345.58M | 27.20%393.7M | 53.85%401.46M | 73.68%498.6M | 67.67%497.08M | -29.65%309.52M |
| Total liabilities | 16.09%56.93B | 5.46%39.08B | 58.12%51.16B | 15.85%36.99B | -1.05%49.04B | 8.01%37.06B | -21.83%32.36B | -12.27%31.93B | -14.86%49.56B | -21.82%34.31B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B | 0.00%1.26B |
| Capital reserve funds | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B |
| Surplus reserve funds | 19.58%46.64B | 20.95%41.12B | 20.95%41.12B | 19.92%39B | 19.92%39B | 9.76%34B | 9.76%34B | 29.34%32.52B | 29.34%32.52B | 27.45%30.97B |
| Retained profit | 5.67%182.79B | 7.09%192.9B | 6.46%173.77B | 8.23%197.05B | 7.26%172.98B | 4.69%180.13B | 3.67%163.23B | 2.31%182.07B | 0.35%161.28B | 17.45%172.06B |
| Other composite income | -63.59%-9.92M | 29.79%-6.37M | -43.17%-8.27M | 18.98%-8.11M | 43.75%-6.06M | 40.88%-9.07M | 61.85%-5.78M | 30.32%-10.01M | 17.21%-10.78M | -53.16%-15.34M |
| Ordinary risk reserve funds | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 0.00%1.06B | 14.44%1.06B |
| Shareholders equity without minority interests | 8.09%233.11B | 9.14%237.71B | 8.79%218.58B | 9.83%239.73B | 9.21%215.67B | 5.37%217.81B | 4.59%200.92B | 5.56%218.28B | 4.19%197.48B | 18.56%206.71B |
| Minority interests | 11.49%8.91B | 38.40%9.98B | 13.66%9.47B | 7.54%8.8B | 7.10%7.99B | 7.01%7.21B | 31.13%8.33B | 0.77%8.19B | 0.54%7.46B | 4.19%6.74B |
| Total shareholder equity | 8.21%242.01B | 10.07%247.69B | 8.98%228.04B | 9.75%248.54B | 9.13%223.66B | 5.42%225.02B | 5.44%209.25B | 5.38%226.46B | 4.05%204.94B | 18.05%213.45B |
| Total liabilityies and equity | 9.62%298.94B | 9.42%286.77B | 15.56%279.21B | 10.50%285.52B | 7.15%272.7B | 5.78%262.08B | 0.73%241.6B | 2.82%258.39B | -0.26%254.5B | 10.26%247.76B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.